RxDoctor Payments Data

Graig Alpert, MD

Family Medicine · Saint Petersburg, FLNPI 1407318405

Payments from drug & device makers

$1,552in general payments, 2019–2025

Across 75 payments — averaging $20.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$343
  • AbbVie$294
  • AstraZeneca$223
  • Lilly USA, LLC$153
  • GSK$144
  • Amgen$108
  • plus $287 from 8 others

What the payments were for

  • Food & beverage$1,552100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,552 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$80,655
Medicare patients
222
Services billed
972

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$84,393
EliquisApixaban34$30,448
XareltoRivaroxaban32$24,522
JardianceEmpagliflozin19$18,750
MounjaroTirzepatide12$14,189
TrulicityDulaglutide14$13,459
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$12,632
FarxigaDapagliflozin Propanediol14$12,164
Tresiba Flextouch U-100Insulin Degludec14$6,943
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$3,992
Rosuvastatin Calcium161$2,949
SynthroidLevothyroxine Sodium33$2,866
Levothyroxine Sodium163$2,014
Atorvastatin Calcium258$2,008
Duloxetine Hcl41$1,795

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$343$84,39366 claims
PfizerEliquis$50$30,44834 claims
Lilly USA, LLCMounjaro, Trulicity$153$27,64726 claims
Johnson & JohnsonXarelto$22$24,52232 claims
GSKTrelegy Ellipta$144$12,63219 claims
AstraZenecaFarxiga$223$12,16414 claims
AbbVieSynthroid$294$2,86633 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Saint Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →